The public health potential of aspirin.
Vainio
Harri
H
Unit of Chemoprevention, International Agency for Research on Cancer, Lyon, France. vainio@iarc.fr
Morgan
Gareth
G
Elwood
Peter
P
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003110:Colonic Neoplasms / Q000517:prevention & control*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin